GRP
CRDF icon

Global Retirement Partners’s Cardiff Oncology CRDF Stock Holding History

Global Retirement Partners’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-350
Closed -$413 – 3382
2023
Q3 		$413 Hold
350
– – ﹤0.01% 3006
2023
Q2 		$515 Hold
350
– – ﹤0.01% 2945
2023
Q1 		$651 Hold
350
– – ﹤0.01% 2854
2022
Q4 		$490 Hold
350
– – ﹤0.01% 2762
2022
Q3 		$1K Hold
350
– – ﹤0.01% 2410
2022
Q2 		$1K Hold
350
– – ﹤0.01% 2386
2022
Q1 		$0 Buy
+350
New +$1.24K ﹤0.01% 2652

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return

Global Retirement Partners's CRDF Position: Q4 2023 in Review

Global Retirement Partners sold out of Cardiff Oncology (CRDF) in Q4 2023, closing a stake of 350 shares — an estimated $413 sold.

Global Retirement Partners first reported a position in CRDF in Q1 2022 and held it in 7 quarters. The position peaked at $1K in Q3 2022. 55 funds tracked by Wall St. Rank hold CRDF as of Q4 2023.

  • Global Retirement Partners reported no remaining Cardiff Oncology position as of Q4 2023 after selling out during the quarter.
  • Global Retirement Partners sold 350 Cardiff Oncology shares in Q4 2023, an estimated $413.
  • Global Retirement Partners first reported a position in Cardiff Oncology in Q1 2022 and held it in 7 quarters.
  • Global Retirement Partners's Cardiff Oncology position peaked at $1K in Q3 2022.
  • 55 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2023.

Based on Global Retirement Partners's 13F filing for Q4 2023, filed 18 Jan 2024.